Codiak BioSciences, Inc.
Codiak BioSciences, Inc. (CDAK) is a publicly traded company in the Unknown sector. Across all available filings, 18 corporate insiders have executed 90 transactions totaling $21.3M, demonstrating a bullish sentiment with $20.3M in net insider flow. The most recent transaction on Mar 30, 2023 involved a sale of 1,628 shares valued at $326.
CDAK Insider Activity Summary
Who Is Buying CDAK Stock?
No significant insider buying has been recorded for CDAK in the recent period.
Who Is Selling CDAK Stock?
No significant insider selling has been recorded for CDAK in the recent period.
Is Codiak BioSciences, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for CDAK is bullish with an Insider Alignment Score of 98/100 and a net flow of $20.3M. Insiders are accumulating shares, which historically signals confidence in the company's future performance.
CDAK Frequently Asked Questions
Understanding CDAK Insider Activity
Insider trading at Codiak BioSciences, Inc. (CDAK) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 18 insiders are actively trading CDAK stock, having executed 90 transactions in the past 90 days. The most active insider is Venture Fund VIII Overage, L.p. Arch (Executive), who has made 1 transactions totaling $7.5M.
Related Tools
Track Codiak BioSciences, Inc. Insider Activity
Get notified when executives and directors at CDAK file new Form 4 transactions